Young Kwon, Ph.D.

Dr. Kwon has been a director of ADMA Biologics since October 2021. He was formerly Chief Executive Officer of Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies in neurodegeneration and oncology.  Dr. Kwon held a variety of leadership roles as a senior executive at Momenta Pharmaceuticals, including as Chief Financial and Business Officer. He led public equity financings raising nearly $500 million and led the company’s sale to Johnson & Johnson for $6.5 billion. Prior to Momenta, Dr. Kwon was a business development professional at Biogen. Dr. Kwon previously worked at the venture capital firm Advanced Technology Ventures, investing in early-stage biotech and medical device companies. Dr. Kwon received a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University.